2 citations
,
April 2016 in “PubMed” This study found that a 12-week regimen of 2% minoxidil combined with a botanical hair solution improved hair growth and patient satisfaction for female pattern hair loss, aiding treatment adherence.
2 citations
,
December 2015 in “DOAJ (DOAJ: Directory of Open Access Journals)” This study reports that targeted anticancer therapies frequently cause skin-related side effects, which may impact patient adherence and quality of life, but these effects are positively correlated with treatment response.
2 citations
,
October 2015 in “Mikrobiyoloji bülteni” This case report describes a 20-year-old female with favus caused by T. schöenleinii, which initially improved with antifungal treatment but recurred due to poor adherence, underscoring favus as an ongoing health issue in Turkey.
2 citations
,
July 2014 in “Irish Journal of Medical Science” The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.
1 citations
,
July 2025 in “Journal of Clinical Medicine” In this review, experts discuss the low but significant risk of serious eye complications from popular minimally invasive cosmetic procedures like fillers and botulinum toxin injections, underscoring the need for awareness, careful patient selection, and adherence to safe practices to help prevent these outcomes.
1 citations
,
December 2023 in “Revista médica de Chile” This review examines the dermatologic side effects of lithium, noting it can cause or worsen skin conditions like psoriasis and acne, potentially affecting medication adherence, but reports no new clinical results.
1 citations
,
July 2014 in “Current psychiatry” This review discusses the guidelines for using and monitoring mood stabilizers in bipolar disorders, highlighting that only a minority of patients receive guideline-adherent monitoring.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” The authors discuss that antifungal hair serums with essential oils and herbal extracts show promise for managing microbial scalp disorders, as they might enhance drug delivery and patient adherence compared to traditional treatments like Ketoconazole, which can have side effects and limited effectiveness.
July 2026 in “Advanced Biology” This study introduces novel wound dressings with hydrophobic properties, highlighting their ability to enhance hemostasis, improve wound adhesion, reduce bacterial adherence, and facilitate exudate removal, and discusses advancements in the development and application of such composite dressings for antibacterial hemostatic purposes.
June 2026 in “Journal of Cosmetic Dermatology” In this study, digital treatment for androgenetic alopecia over six months led to significant improvements in quality of life among Brazilian men, particularly for those with consistent program adherence, although the absence of an in-person comparator limits causal conclusions.
This case report highlights hair loss as a side effect of tacrolimus-based immunosuppression in a kidney transplant patient, improving after switching to cyclosporine A. The authors emphasize the importance of monitoring and managing such side effects to ensure treatment adherence and patient well-being.
This case report from a kidney transplant patient highlights significant alopecia linked to tacrolimus-based immunosuppression, with improvement seen after switching to cyclosporine A, emphasizing the importance of monitoring and managing hair loss to support treatment adherence and patient quality of life.
January 2026 in “Revista Colombiana de Ciencias Químico Farmacéuticas” This review discusses the efficacy of Minoxidil and finasteride for treating androgenetic alopecia and suggests that combined therapy may offer superior results and improved patient adherence despite potential side effects.
January 2026 in “Magazine Portal Bibliotech Digital (Universidad Nacional de Colombia)” This study reviewed the literature on Minoxidil and finasteride for androgenetic alopecia, finding both drugs effective but noting potential side effects, with combined therapy possibly enhancing efficacy and patient adherence while reducing adverse effects.
January 2026 in “Skin Appendage Disorders” This study found that hair shedding occurs in seven out of ten users of GLP-1 receptor agonists in real-world settings, a much higher prevalence than in clinical trials, which affects treatment adherence, especially among women experiencing significant weight loss.
December 2025 in “International Journal of Research in Dermatology” In this survey, dermatologists in India reported preferring alcohol-free minoxidil combined with procapil and finasteride over traditional alcohol-based formulations for managing androgenetic alopecia, citing better tolerance and patient adherence.
December 2025 in “Clinical and Translational Science” This review highlights that chemotherapy-induced skin toxicities from EGFR inhibitors in breast cancer treatment can significantly impact patient quality of life and treatment adherence, emphasizing the importance of proactive management and patient discussions.
This study detailed a comprehensive hair therapy regimen for a 22-year-old male with androgenetic alopecia, observing significant improvements in scalp health and hair density over four months, though benefits regressed after stopping treatment, emphasizing the need for continuous adherence and multidisciplinary support.
June 2025 in “Experimental and Сlinical Urology” This research found that the new combination drug Predstanormix Duo, with dutasteride and tamsulosin, is bioequivalent to established treatments for benign prostatic hyperplasia, showing similar pharmacokinetics and safety, potentially improving treatment availability and adherence in high-risk patients.
June 2025 in “British Journal of Clinical Pharmacology” This study highlights the significant impact of cutaneous side effects associated with anticancer therapies, emphasizing the need for proactive management to improve patient quality of life and treatment adherence.
March 2025 in “Journal of Education Health and Sport” This review reported that while finasteride is effective for treating androgenetic alopecia and benign prostatic hyperplasia, it may cause adverse effects such as sexual dysfunction and psychological symptoms, which require careful patient education and management to ensure treatment adherence and satisfaction.
January 2025 in “Editora Acadêmica Periodicojs eBooks” This review found that low-dose oral Minoxidil may be a viable alternative to topical Minoxidil for treating androgenetic alopecia, offering similar efficacy but with better adherence and different side effect profiles; consideration of patient-specific factors is important for treatment choice.
January 2025 in “The Pharma Innovation” This review discusses how nanospanlastics, a type of ultra deformable vesicular nanocarrier, could enhance glaucoma management by improving the delivery and effectiveness of intraocular pressure-lowering agents, tackling adherence challenges, and advancing targeted therapies, according to the authors.
January 2025 in “ARC Journal of Urology” This review reports that treatments for urological cancers, such as chemotherapy and immunotherapy, often result in significant dermatological side effects that negatively affect patients' quality of life and treatment adherence, highlighting a need for better management strategies and further research.
In this retrospective study of 133 pediatric patients, topical minoxidil was generally well tolerated for managing androgenetic alopecia, but close monitoring and adherence to treatment, accounting for hormonal and concurrent conditions, were emphasized for effective care.
November 2024 in “RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218” In this study, a literature review concluded that minoxidil is safe and effective for treating androgenetic alopecia, with few side effects, and highlighted the role of pharmacists in optimizing treatment by monitoring use and fostering adherence.
May 2024 in “Journal of cosmetic dermatology” This study found that topical finasteride mixed with minoxidil improved hair appearance and self-esteem in men with androgenetic alopecia, but it was not superior to oral finasteride and had lower treatment adherence.
September 2023 in “International Journal For Multidisciplinary Research” In this case report, a 29-year-old woman with PCOS experienced significant improvement in symptoms and ultrasound findings after three months of Ayurvedic treatment, suggesting potential benefits of adherence to Ayurvedic principles for managing PCOS.
July 2023 in “International journal of dermatology, venereology and leprosy sciences” This review discusses the increased prevalence of androgenic alopecia in men and women, highlighting the limited FDA-approved treatment options, and reports no clinical results; the authors note adherence challenges due to prolonged drug use.
January 2022 in “Indian Journal of Psychiatry/Indian journal of psychiatry” This case report describes a patient who developed a maculopapular rash after starting lithium treatment, highlighting the importance of monitoring skin reactions due to potential impact on treatment adherence.